Skip to main content Skip to main navigation menu Skip to site footer
Bleeding, Thrombosis and Vascular Biology

Editor-in-Chief: Giovanni de Gaetano, Italy | eISSN: 2785-5309

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Copyright
  • Special Issues
    • Overview
  • Register
  • Login
  • Search
  • Contacts
  • News
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Pathways for lower extremity superficial vein thrombosis management in an academic medical center

    Gisoo Imani, Aaron Wilson, Sara Vazquez, Daniel M. Witt
    24-03-2025
    https://doi.org/10.4081/btvb.2025.155
    193
    PDF: 40
  • Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy

    Gary E. Raskob
    16-05-2024
    https://doi.org/10.4081/btvb.2024.124
    559
    PDF: 227
  • Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

    Agnes Y.Y. Lee
    29-02-2024
    https://doi.org/10.4081/btvb.2024.111
    1466
    PDF: 314
  • Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review

    Rosina Albisinni, Tommaso Marrazzo, Arta Karruli, Sabrina Manduca, Giuseppe Nobile, Nicola Galdieri, Marisa De Feo
    24-10-2022
    https://doi.org/10.4081/btvb.2022.44
    569
    PDF: 185
  • The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

    Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno
    04-09-2024
    https://doi.org/10.4081/btvb.2024.144
    888
    PDF: 201
    SUPPLEMENTARY MATERIAL: 93
  • Cancer-associated ischemic stroke: current knowledge and future directions

    Ronda Lun, Deborah M. Siegal
    16-05-2024
    https://doi.org/10.4081/btvb.2024.117
    1848
    PDF: 474
  • Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

    Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci
    14-12-2022
    https://doi.org/10.4081/btvb.2022.50
    807
    PDF: 312
  • Crosstalk between hemostasis inhibitors and cholesterol biomarkers in multiple sclerosis

    Robert Parambi, Nicole Ziliotto, Francesco Bernardi , Marcello Baroni , Richard W Browne , Dejan Jakimovski, Bianca Weinstock-Guttman, Robert Zivadinov, Murali Ramanathan
    17-10-2022
    https://doi.org/10.4081/btvb.2022.41
    2252
    PDF: 240
    Supplementary Files: 60
  • Factor XI inhibitors: a new option for the prevention and treatment of cancer-associated thrombosis

    Marcello Di Nisio, Matteo Candeloro, Nicola Potere, Ettore Porreca, Jeffrey I. Weitz
    16-05-2024
    https://doi.org/10.4081/btvb.2024.118
    807
    PDF: 311
  • New perspectives for prevention of the post-thrombotic syndrome

    Paolo Prandoni
    22-03-2022
    https://doi.org/10.4081/btvb.2022.20
    1457
    PDF: 445
  • The changing landscape of treatment for acquired hemophilia A

    Massimo Franchini, Daniele Focosi
    30-01-2025
    https://doi.org/10.4081/btvb.2025.157
    811
    PDF: 264
  • New drugs, old problems: immune checkpoint inhibitors and cancer-associated thrombosis

    Mehrie H. Patel, Alok A. Khorana
    16-05-2024
    https://doi.org/10.4081/btvb.2024.113
    532
    PDF: 247
  • Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

    Ang Li, Emily Zhou
    16-05-2024
    https://doi.org/10.4081/btvb.2024.108
    731
    PDF: 281
  • Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

    Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni
    03-11-2022
    https://doi.org/10.4081/btvb.2022.42
    870
    PDF: 286
  • Venous thromboembolism and mortality in patients with hematological malignancies

    Kristen M. Sanfilippo, Tzu-Fei Wang
    16-05-2024
    https://doi.org/10.4081/btvb.2024.119
    683
    PDF: 242
  • Long-term persistence of high anti-PF4 antibodies titer in a challenging case of AZD1222 vaccine-induced thrombotic thrombocytopenia

    Luca Barcella, Chiara Ambaglio, Paolo Gritti, Francesca Schieppati, Varusca Brusegan, Eleonora Sanga, Marina Marchetti, Luca Lorini, Anna Falanga
    28-06-2023
    https://doi.org/10.4081/btvb.2023.72
    575
    PDF: 193
  • Stroke in women: anticoagulation in a complicated puzzle

    Francesco Marongiu, Elvira Grandone, Silvia Marongiu, Antonella Mameli, Doris Barcellona
    26-08-2024
    https://doi.org/10.4081/btvb.2024.137
    1090
    PDF: 288
  • Diagnosis and management of abnormal uterine bleeding in adolescence An expert Consensus Statement of SIGO (Italian Society of Gynecology and Obstetrics) and SISET (Italian Society for the Study of Hemostasis and Thrombosis)

    Roberto Mario Santi, Annamaria Fulghesu, Ezio Zanon, Erica De Candia, Elvira Grandone, Giancarlo Di Renzo, Claudia Succu, Valentina Tosto, Vincenzina Bruni, Paolo Gresele
    08-05-2024
    https://doi.org/10.4081/btvb.2024.106
    860
    PDF: 334
  • Management of atrial fibrillation: a practical and useful synopsis of last guidelines

    Gualtiero Palareti
    24-02-2025
    https://doi.org/10.4081/btvb.2025.168
    715
  • Rationale and design of a study on D-dimer use to stratify patients after a first unprovoked venous thromboembolism for their risk of recurrence: extended low-dose Apixaban given only to patients with positive D-dimer results The Apidulcis study

    Gualtiero Palareti, Paolo Prandoni, Cristina Legnani, Emilia Antonucci, Serena Zorzi, Alberto Tosetto, Lorenza Bertù, Sophie Testa, Vittorio Pengo, Walter Ageno, Ida Martinelli, Benilde Cosmi, Eugenio Bucherini, Daniela Poli
    22-03-2022
    https://doi.org/10.4081/btvb.2022.10
    1055
    PDF: 339
    APPENDIX: 69
  • Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life

    Ilaria Nichele, Giuseppe Carli, Alberto Tosetto
    22-04-2024
    https://doi.org/10.4081/btvb.2024.104
    423
    PDF: 138
  • Major bleedings in mechanical prosthetic heart valves patients on Vitamin K antagonist treatment. Data from the PLECTRUM Study

    Daniela Poli, Emilia Antonucci, Gualtiero Palareti, Roberto Facchinetti, Pietro Falco, Giuseppina Serricchio, Teresa Lerede, Lucilla Masciocco, Paolo Gresele, Sophie Testa
    27-07-2022
    https://doi.org/10.4081/btvb.2022.34
    4607
    PDF: 392
    Supplementary Files: 119
  • Welcome to the 12th International Conference on Thrombosis and Hemostasis Issues in Cancer! Proceedings

    Anna Falanga, Benjamin Brenner, Alok A. Khorana
    16-05-2024
    https://doi.org/10.4081/btvb.2024.138
    1410
    PDF: 259
  • Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care

    Gianfranco De Girolamo, Luca Sarti, Sonia Cecoli, Karin Bonora, Chiara Ajolfi, Francesco Bellelli, Valeria Coluccio, Gualtiero Palareti, Marco Marietta
    15-04-2022
    https://doi.org/10.4081/btvb.2022.9
    664
    PDF: 216
    Supplementary Files: 69
  • Polycythemia vera and management of the thrombotic risk: an update

    Massimo Franchini
    20-12-2023
    https://doi.org/10.4081/btvb.2023.102
    1875
    PDF: 279
  • Treatment of venous thromboembolism in pregnancy: findings from the RIETE Registry

    Paolo Prandoni, Franca Bilora, Raffaele Pesavento, Giorgina Salgueiro, Angeles Blanco-Molina, Raquel Lòpez-Reyes, Manuel Monreal, and the RIETE Investigators
    23-05-2022
    https://doi.org/10.4081/btvb.2022.28
    5212
    PDF: 452
    APPENDIX: 122
  • Influence of emicizumab on protein C-mediated clotting regulation

    Federica Mancazzo, Antonia Vitulli, Lavinia Dirienzo, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci
    25-10-2023
    https://doi.org/10.4081/btvb.2023.89
    1983
    PDF: 231
    Supplementary Material: 47
  • Antithrombotic therapy in idiopathic infertility

    Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso
    03-10-2024
    https://doi.org/10.4081/btvb.2024.126
    1938
    PDF: 451
  • Vaccine-induced immune thrombotic thrombocytopenia following ChAdOx1 nCoV-19 vaccine: report of two cases

    Rita Carlotta Santoro, Roberto Minici, Marzia Leotta, Mariapia Falbo, Lucia Concetta Elia, Francesca Leo, Antonella Ierardi, Alessandra Strangio, Simona Prejanò
    23-05-2022
    https://doi.org/10.4081/btvb.2022.23
    3742
    PDF: 267
  • Identifying novel biomarkers using proteomics to predict cancer-associated thrombosis

    Maria J. Fernandez Turizo, Rushad Patell, Jeffrey I. Zwicker
    16-05-2024
    https://doi.org/10.4081/btvb.2024.120
    755
    PDF: 318
  • Descriptive analysis of patients positive for anti-phospholipid antibodies included in two Italian registries

    Vittorio Pengo, Luca Sarti, Emilia Antonucci, Stefania Di Agostino, Elisa Bison, Gentian Denas, Daniela Poli, Pier Luigi Meroni, Roberto Gerli, Antonella Radice, Gualtiero Palareti, on behalf of FIRMA group and START collaborators
    12-10-2023
    https://doi.org/10.4081/btvb.2023.92
    797
    PDF: 224
  • A nitric oxide-donor pravastatin hybrid drug exerts antiplatelet and antiatherogenic activity in mice

    Stefania Momi, Giuseppe Guglielmini, Giulia Ciarroca Taranta, Elisa Giglio, Angela Monopoli, Paolo Gresele
    23-05-2022
    https://doi.org/10.4081/btvb.2022.19
    4653
    PDF: 266
  • Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”

    Ottavia Borghese, Claudio Vincenzoni
    26-06-2024
    https://doi.org/10.4081/btvb.2024.141
    1011
    PDF: 255
  • The night of randomized clinical trials where all patients are black: a need to estimate variability in treatment effects

    Giovanni de Gaetano, Chiara Cerletti, Licia Iacoviello, Maria Benedetta Donati
    22-03-2022
    https://doi.org/10.4081/btvb.2022.24
    1783
    PDF: 254
  • Palestinian patients associations appeal on World Hemophilia Day

    Sara Mellano
    17-04-2024
    https://doi.org/10.4081/btvb.2024.136
    342
    PDF: 99
  • The evolution of hemostasis genetics: from monogenic disorders to complex traits. A historical perspective

    Augusto Di Castelnuovo
    01-07-2025
    https://doi.org/10.4081/btvb.2025.184
    44
    PDF: 19
  • A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

    Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti
    09-03-2023
    https://doi.org/10.4081/btvb.2023.53
    692
    PDF: 351
  • Talking about assisted reproductive techniques and thromboembolic risk: everything we always wanted to know

    Giovanni Tiscia, Elvira Grandone
    13-09-2022
    https://doi.org/10.4081/btvb.2022.43
    2193
    PDF: 255
  • Interaction between adenosine diphosphate receptors and protein-kinase C isoforms in platelet adhesion under flow condition

    Boris Shenkman, Ivan Budnik, Yulia Einav
    16-02-2023
    https://doi.org/10.4081/btvb.2023.51
    1268
    pdf: 219
  • Ankle brachial index for the diagnosis of asymptomatic lower extremity peripheral arterial disease

    Francesco Cicconi
    05-07-2024
    https://doi.org/10.4081/btvb.2024.128
    1312
    PDF: 352
  • Location of metastasis and complications in patients with venous thromboembolism and cancer: a systematic review

    Maria Barca-Hernando, Victor Garcia-Garcia, Luis Jara-Palomares
    16-05-2024
    https://doi.org/10.4081/btvb.2024.114
    503
    PDF: 187
  • Thrombosis and hemostasis at the University of Padua: a reappraisal on the occasion of its 800th year of history

    Paolo Simioni, Vittorio Pengo, Paolo Prandoni
    07-11-2022
    https://doi.org/10.4081/btvb.2022.52
    2012
    PDF: 224
1 - 42 of 42 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a scientific paper
  • How to write a Review article
  • Index of Authors

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to review

aice

Affiliated Scientific Society

indexing

INDEXING
  • DOAJ
  • Google Scholar
  • OpenAlex
  • Analytics
Vol. 4 No. 2 (2025)
A commitment to global collaboration, welcoming international participation and advancing science for the benefit of patients
Pantep Angchaisuksiri et al.
1 July 2025
Vol. 4 No. 2 (2025)
2024 EACTS guidelines on perioperative medication in adult cardiac surgery: embracing precision medicine driven by strong evidence-based methodology
Bianca Rocca et al.
1 July 2025
Vol. 4 No. 2 (2025)
Comment on "Apixaban vs. aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or...
Vittorio Pengo
1 July 2025

Keywords

Bleeding, Thrombosis and Vascular Biology

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

eISSN: 2785-5309

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

Themes by Openjournaltheme.com

© PAGEPress 2008-2025    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy